Average Co-Inventor Count = 5.48
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (12 from 2,078 patents)
2. University of Pennsylvania (1 from 2,597 patents)
13 patents:
1. 10118900 - Benzimidazole derivatives useful as CB-1 inverse agonists
2. 10112895 - Antivirals against molluscum contagiosum virus
3. 10077261 - Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
4. 9732061 - Cinnoline derivatives useful as CB-1 receptor inverse agonists
5. 9682940 - Indazole derivatives useful as CB-1 inverse agonists
6. 8853263 - Co-therapy for the treatment of epilepsy and related disorders
7. 8815939 - Substituted sulfamide derivatives
8. 8686152 - 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1)
9. 8633322 - Alkynyl derivatives useful as DPP-1 inhibitors
10. 8481547 - Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1
11. 8084490 - Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
12. 7932261 - Macrocycle derivatives useful as inhibitors of β-secretase (BACE)
13. 7531545 - 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE)